These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8106675)

  • 1. Neuromuscular blocking drugs in the intensive care unit: introductory remarks.
    Bion JF; Pollard BJ
    Intensive Care Med; 1993; 19 Suppl 2():S35. PubMed ID: 8106675
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular blocking agents and sedative drugs. Clinical uses and toxic effects in the critical care unit.
    Durbin CG
    Crit Care Clin; 1991 Jul; 7(3):489-506. PubMed ID: 1863878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular-blocking drugs. Use and misuse in the intensive care unit.
    Murphy GS; Vender JS
    Crit Care Clin; 2001 Oct; 17(4):925-42. PubMed ID: 11762268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blocking agents in intensive care.
    Pollard BJ
    Intensive Care Med; 1993; 19 Suppl 2():S36-9. PubMed ID: 8106676
    [No Abstract]   [Full Text] [Related]  

  • 5. Sedation and neuromuscular blockade in paediatric intensive care; practice in the United Kingdom and North America.
    Crean P
    Paediatr Anaesth; 2004 Jun; 14(6):439-42. PubMed ID: 15153203
    [No Abstract]   [Full Text] [Related]  

  • 6. Nursing care of patients receiving long-term infusion of neuromuscular blocking agents.
    Jarpe MB
    Crit Care Nurse; 1992 Oct; 12(7):58-63. PubMed ID: 1478105
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of neuromuscular blocking drugs in the intensive care unit: a US perspective.
    Murray MJ; Strickland RA; Weiler C
    Intensive Care Med; 1993; 19 Suppl 2():S40-4. PubMed ID: 8106677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular blocking drugs: practical aspects of research in the intensive care unit.
    Harper NJ
    Intensive Care Med; 1993; 19 Suppl 2():S80-5. PubMed ID: 8106683
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of Continuous Infusion Neuromuscular Blocking Agents in the Adult Intensive Care Unit.
    Smetana KS; Roe NA; Doepker BA; Jones GM
    Crit Care Nurs Q; 2017; 40(4):323-343. PubMed ID: 28834856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of muscle relaxants in the intensive care unit.
    Sharpe MD
    Can J Anaesth; 1992 Nov; 39(9):949-62. PubMed ID: 1451224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring neuromuscular function in the intensive care unit.
    Viby-Mogensen J
    Intensive Care Med; 1993; 19 Suppl 2():S74-9. PubMed ID: 8106682
    [No Abstract]   [Full Text] [Related]  

  • 12. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients.
    Mehta S; Burry L; Fischer S; Martinez-Motta JC; Hallett D; Bowman D; Wong C; Meade MO; Stewart TE; Cook DJ;
    Crit Care Med; 2006 Feb; 34(2):374-80. PubMed ID: 16424717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blocking agents in the intensive care unit: a two-edged sword.
    Khuenl-Brady KS; Sparr HJ; Waibel U
    Crit Care Med; 1996 Apr; 24(4):717-9. PubMed ID: 8612428
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular blocking agents in critical care.
    Susla GM
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):297-311. PubMed ID: 8398037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.
    Rhoney DH; Murry KR
    J Intensive Care Med; 2003; 18(3):139-45. PubMed ID: 14984632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should ICU patients receive muscle relaxants?
    Coakley J
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1644-8. PubMed ID: 8858758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring neuromuscular function.
    Monti EJ; Kerr ME; Bender C
    J Neurosci Nurs; 1995 Aug; 27(4):252-7. PubMed ID: 7499932
    [No Abstract]   [Full Text] [Related]  

  • 18. Case presentation: Undertreatment of pain: a risk associated with neuromuscular blockade in the intensive care unit.
    Pigazzi A; Manfredi PL
    J Pain Symptom Manage; 2000 Feb; 19(2):154. PubMed ID: 10699542
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromuscular blockade in the intensive care unit.
    Lewis KS; Rothenberg DM
    Am J Health Syst Pharm; 1999 Jan; 56(1):72-5. PubMed ID: 10048882
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of neuromuscular blocking drugs in intensive care unit patients.
    Miller RD
    Anesth Analg; 1995 Jul; 81(1):1-2. PubMed ID: 7598234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.